Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
MM-129 is a novel inhibitor targeting BTK/PI3K/AKT/mTOR and PD-L1, as it possesses antitumor activity against colon cancer. To evaluate the safety profile of MM-129, we conducted a toxicity study using the zebrafish and rodent model. MM-129 was also assessed for pharmacokinetics features through an...
Saved in:
Main Authors: | , , , , , , |
---|---|
格式: | 图书 |
出版: |
MDPI AG,
2021-08-01T00:00:00Z.
|
主题: | |
在线阅读: | Connect to this object online. |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
索引号: |
A1234.567 |
---|---|
复印件 1 | 可用 |